Xueyan He Selected Research

Xueyan He Research Topics

11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
9	Neoplasms (Cancer) 01/2022 - 11/2017
3	Triple Negative Breast Neoplasms 01/2020 - 01/2018
1	Tics (Tic) 12/2021
1	Carcinogenesis 12/2021
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Lymphatic Metastasis 11/2017
1	Stomach Neoplasms (Stomach Cancer) 11/2017

3	Aldehyde DehydrogenaseIBA 12/2021 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2017
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2022
1	EnzymesIBA 12/2021
1	Disulfiram (Antabuse)FDA Link 12/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2021
1	Gemcitabine FDA Link 12/2021
1	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 01/2021
1	Uncoupling Protein 1IBA 01/2021
1	ribophorinIBA 01/2021
1	Notch4 ReceptorIBA 01/2020
1	moesinIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	NucleoproteinsIBA 01/2020
1	Protein Kinase CIBA 01/2020
1	Interleukin-1 Type II ReceptorsIBA 01/2020
1	glycylpeptide N-tetradecanoyltransferaseIBA 11/2018
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2018
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	taxaneIBA 01/2018
1	3- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Annexin A3IBA 01/2018
1	ChemokinesIBA 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	LigandsIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 11/2017

3	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
1	Therapeutics 01/2020